CCK-8 assay revealed that the inhibition of si-SBF2-AS1 on NSCLC cells proliferation was relieved by the cotransfection of the miR-520a-3p inhibitor (Figure 5(b)). The gene discussed is SBF2; the disease is non-small cell lung carcinoma.